The U.S Drug Enforcement Administration has finally allowed private companies to cultivate their own marijuana, ending the 52-year monopoly. Many large-scale marijuana growers can now produce cannabis for federal research.
This decision will help to prove that cannabis contains medicinal properties that relieve pain and anxiety. According to Bruce Williams, the cannabis bred at the University of Mississippi has low-THC. John Hopkins University withdrew from a medical marijuana trial because they couldn’t get marijuana containing at least 12 percent THC from the federal agency.
Scottsdale Research Institute‘s scientists were involved in the trial and maintained that what they got didn’t smell or look like marijuana.
You can also read: Endangered Red Wolf Pups Birthed in North Carolina
In another case, a scientist in Massachusetts filed a lawsuit against the US. DEA claiming that they didn’t review his application to produce cannabis for a trial for Multidisciplinary Association for Psychedelic Studies.
It appeared that the U.S Drug Enforcement Administration has got about 33 applications requesting for such since 2016 and it seemed they were all shelved. On the 14th of May, the DEA announced its plans to register more authorized entities to cultivate cannabis for research and the Scottsdale Research Institute is among those entities.
The DEA has now publicly approved several applications. Attorney Mathew Zorn said that scientists can now conduct their research on the type of marijuana people are using.
A lot of people may not appreciate the importance of that, with [national cannabis] legalization around the corner. We don’t know when, but the need for this research is urgent. We can as quickly as possible start growing and have a supply for researchers to get good data.Mathew Zorn